31 articles for T Nguyen
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.

Amgen
Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.

Research Triangle Institute
Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility.

TBA
Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo.

University of Athens
Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation.

Virginia Commonwealth University
Preparation and evaluation of deconstruction analogues of 7-deoxykalafungin as AKT kinase inhibitors.

Virginia Commonwealth University
Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

Califia Bio
Inhibition of human topoisomerases I and II by simocyclinone D8.

University of Minnesota Medical School
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of ß-Secretase.

TBA
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.

Amgen
5-ureidobenzofuranone indoles as potent and efficacious inhibitors of PI3 kinase-alpha and mTOR for the treatment of breast cancer.

Wyeth Research
Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).

Cytopia Research
Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitors.

Amgen
Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers.

Cytrx
Neuropeptide B/W receptor 1 peptidomimetic agonists: Structure-activity relationships and plasma stability.

Rti International
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior.

Research Triangle Institute
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.

Research Triangle Institute
Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development.

Research Triangle Institute
Nostotrebin 6 Related Cyclopentenediones and δ-Lactones with Broad Activity Spectrum Isolated from the Cultivation Medium of the Cyanobacterium

University of Halle-Wittenberg
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.

Research Triangle Institute
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na

Genentech
Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.

Virginia Commonwealth University
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.

Epichem
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.

Research Triangle Institute
Aminopyrrolotriazines as kinase inhibitors

Bristol-Myers Squibb
Heteroaromatic compounds as BTK inhibitors

Boehringer Ingelheim International
Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.

Shanghai Institutes For Biological Sciences
Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.

University of Zurich
Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.

Abbott Laboratories
Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors.

Emory University